SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-214163
Filing Date
2020-08-10
Accepted
2020-08-10 08:17:22
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d911713d10q.htm   iXBRL 10-Q 1457029
2 EX-10.2 d911713dex102.htm EX-10.2 47009
3 EX-10.3 d911713dex103.htm EX-10.3 39770
4 EX-10.4 d911713dex104.htm EX-10.4 45463
5 EX-10.5 d911713dex105.htm EX-10.5 41938
6 EX-31.1 d911713dex311.htm EX-31.1 6788
7 EX-31.2 d911713dex312.htm EX-31.2 6934
8 EX-32 d911713dex32.htm EX-32 6003
  Complete submission text file 0001193125-20-214163.txt   6942485

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA itci-20200630.xsd EX-101.SCH 39546
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20200630_cal.xml EX-101.CAL 34961
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20200630_def.xml EX-101.DEF 257550
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20200630_lab.xml EX-101.LAB 394640
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20200630_pre.xml EX-101.PRE 363986
14 EXTRACTED XBRL INSTANCE DOCUMENT d911713d10q_htm.xml XML 1222800
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 201087218
SIC: 2834 Pharmaceutical Preparations